| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Hydrocortisone Impurity 58 |
17α-羥基黃體酮 |
68-96-2 |
詳細(xì)
|
| Atracurium Enantiomer (Benzene sulfonate) |
阿曲庫(kù)銨對(duì)映異構(gòu)體(苯磺酸鹽) |
|
詳細(xì)
|
| Mosapride Impurity 22 |
(4-芐基-1,4-氧雜-2-基)甲胺 |
110859-47-7 |
詳細(xì)
|
| Loxoprofen Impurity 50 |
洛索洛芬雜質(zhì)15 |
1091621-62-3 |
詳細(xì)
|
| Cilastatin |
西司他丁 |
82009-34-5 |
詳細(xì)
|
| Upadacitinib Impurity 99 |
烏帕替尼雜質(zhì)99 |
|
詳細(xì)
|
| Bumetanide Impurity 8 |
4-Hydroxy-3-nitro-5-sulfamoylbenzoic acid |
32642-56-1 |
詳細(xì)
|
| Piperonyl alcohol |
胡椒醇 |
495-76-1 |
詳細(xì)
|
| Ropinirole EP Impurity F |
1,3-二氫-4-(2-羥乙基)-2H-吲哚-2-酮 |
139122-19-3 |
詳細(xì)
|
| Mivacurium Chloride Impurity 29 |
米庫(kù)氯銨雜質(zhì)29 |
|
詳細(xì)
|
| Loratadine Impurity 43 |
氯雷他定雜質(zhì)25 |
107256-32-6 |
詳細(xì)
|
| Allisartan Isoproxil Impurity 5 |
阿利沙坦酯雜質(zhì)5 |
135050-95-2 |
詳細(xì)
|
| Butyphthalide impurity3 |
3-丁基-3-羥基異苯并呋喃-1(3H)-酮 |
162050-42-2 |
詳細(xì)
|
| Iguratimod Impurity 27 |
Iguratimod |
123663-50-3 |
詳細(xì)
|
| Blonanserin Impurity 21 |
布南色林雜質(zhì)8 |
132810-93-6 |
詳細(xì)
|
| Olodaterol Impurity 9 |
6-芐氧-8-((R)-2-氯-1-羥基-乙基-4H-苯并[1,4]-噁嗪-3-酮 |
869478-11-5 |
詳細(xì)
|
| Vildagliptin Impurity 57 (4-Methylbenzenesulfonate) |
維格列汀雜質(zhì)57(對(duì)甲苯磺酸鹽) |
|
詳細(xì)
|
| Dobutamine Impurity 15 |
多巴酚丁胺雜質(zhì) 15 |
|
詳細(xì)
|
| Ilaprazole Impurity 22 |
蘭索拉唑雜質(zhì)B-6 |
1805648-51-4 |
詳細(xì)
|
| Bumetanide Impurity 36 |
布美他尼雜質(zhì)36 |
|
詳細(xì)
|
| Bromocriptine EP Impurity F |
BroMocriptine IMpurity F |
82773-21-5 |
詳細(xì)
|
| Cilastatin EP Impurity A |
西司他丁EP雜質(zhì)A |
|
詳細(xì)
|
| Upadacitinib Impurity 58 |
烏帕替尼雜質(zhì)24 |
406-11-1 |
詳細(xì)
|
| Brivaracetam Impurity 61 |
(Z)-2-propylhept-2-enal |
95667-14-4 |
詳細(xì)
|
| Ibrutinib Impurity 49 |
1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-(dimethylamino)-ethanone |
1839150-56-9 |
詳細(xì)
|
| Nicardipine Impurity 19 |
3-(2-hydroxyethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
85677-95-8 |
詳細(xì)
|
| Clevidipine Butyrate Impurity 17 |
2,3-二氯芐叉二氯 |
57058-14-7 |
詳細(xì)
|
| Eperisone Impurity 7(Hydrochloride) |
2-甲基-3-哌啶基苯丙酮 |
6281-80-7 |
詳細(xì)
|
| Upadacitinib Impurity 9 |
烏帕替尼雜質(zhì)9 |
|
詳細(xì)
|
| Haloperidol Decanoate |
氟哌啶醇癸酸酯 |
74050-97-8 |
詳細(xì)
|
| Glipizide Impurity 39 |
格列喹酮二甲基化物:7-甲氧基-2,4,4-三甲基異喹啉-1,3-(2H,4H)-二酮 |
191988-38-2 |
詳細(xì)
|
| Canagliflozin Impurity 83 |
卡格列凈雜質(zhì)83 |
|
詳細(xì)
|
| Mosapride Impurity 9 |
4-氨基-5-氯-2-乙氧基苯甲酸 |
108282-38-8 |
詳細(xì)
|
| Upadacitinib Impurity 87 |
烏帕替尼雜質(zhì)87 |
|
詳細(xì)
|
| Axitinib Impurity 13 |
阿西替尼雜質(zhì) IMYF |
1443118-71-5 |
詳細(xì)
|
| Olodaterol Impurity 19 |
奧達(dá)特羅雜質(zhì)19 |
|
詳細(xì)
|
| Lasmiditan Impurity 29(Hydrochloride) |
拉米地坦雜質(zhì)29(鹽酸鹽) |
|
詳細(xì)
|
| Dobutamine Impurity 7(Hydrochloride) |
多巴酚丁胺雜質(zhì)7(鹽酸鹽) |
|
詳細(xì)
|
| Nicardipine Impurity 25 |
Nimodipine Impurity 3 |
101072-61-1 |
詳細(xì)
|
| Amikacin Impurity 11 |
4-O-(6-氨基-6-脫氧-ALPHA-D-吡喃葡萄糖基)-N1-[(2S)-4-氨基-2-羥基-1-氧代丁基]-2-脫氧-D-鏈霉胺 |
1793053-90-3 |
詳細(xì)
|
| Lornoxicam Impurity 7 |
N-(2-吡啶基)乙酰胺酸 |
13120-39-3 |
詳細(xì)
|
| Dapagliflozin Impurity 100 |
達(dá)格列凈雜質(zhì)100 |
|
詳細(xì)
|
| Ziprasidone EP Impurity E |
齊拉西酮雜質(zhì)E |
1159977-04-4 |
詳細(xì)
|
| Isavuconazole Impurity 28 |
艾沙康唑雜質(zhì)28 |
|
詳細(xì)
|
| Albuterol Impurity 36 |
沙丁胺醇雜質(zhì)36 |
|
詳細(xì)
|
| Dobutamine Impurity 26 |
鹽酸多巴酚丁胺雜質(zhì)5 |
24997-88-4 |
詳細(xì)
|
| Dapagliflozin Impurity 72 |
達(dá)格列凈雜質(zhì)A |
1632287-34-3 |
詳細(xì)
|
| Mosapride citrate Impurity B |
莫沙必利N氧化物 |
1161443-73-7 |
詳細(xì)
|
| Rosuvastatin Intermediate Impurity 2 |
甲基-4-(4-氟苯基)-2-羥基-6-異丙基嘧啶-5-羧酸 |
488798-37-4 |
詳細(xì)
|
| Loxoprofen Impurity 62 |
洛索洛芬雜質(zhì)14 |
99807-55-3 |
詳細(xì)
|
| Baloxavir Impurity 56 |
巴洛沙韋雜質(zhì)56 |
|
詳細(xì)
|
| Iguratimod Impurity 32(Hydrochloride) |
2-氨基-1-(2-甲氧基-4-甲磺酰胺基-5-苯氧基苯基)乙酮鹽酸鹽 |
149436-41-9 |
詳細(xì)
|
| Methyldopa Impurity 4(Hydrochloride) |
甲基多巴雜質(zhì)4(鹽酸鹽) |
|
詳細(xì)
|
| Brivaracetam Impurity 59 |
布魯伐西坦雜質(zhì)17 |
2167633-39-6 |
詳細(xì)
|
| Upadacitinib Impurity 86 |
烏帕替尼雜質(zhì)86 |
|
詳細(xì)
|
| Upadacitinib Impurity 82 |
烏帕替尼雜質(zhì)82 |
|
詳細(xì)
|
| Upadacitinib Impurity 47 |
烏帕替尼雜質(zhì)47 |
1944483-53-7 |
詳細(xì)
|
| Rosuvastatin Impurity 150 |
瑞舒伐他汀雜質(zhì)150 |
|
詳細(xì)
|
| Rosuvastatin Impurity 151 |
瑞舒伐他汀雜質(zhì)151 |
|
詳細(xì)
|
| Morinidazole Impurity 9 |
1-甲基-1,2-雙（2-甲基-5-硝基-1H-咪唑-1-基）乙醇 |
74550-92-8 |
詳細(xì)
|
| Olodaterol Impurity 15 |
奧達(dá)特羅雜質(zhì)15 |
|
詳細(xì)
|
| Venetoclax Impurity 6 |
2-[(1H-吡咯并[2,3-B]吡啶-5-基)氧基]-4-[4-[[2-(4-氯苯基)-4,4-二甲基環(huán)己-1-烯基]甲基]哌嗪-1-基]苯甲酸甲酯 |
1235865-76-5 |
詳細(xì)
|
| Haloperidol Decanoate EP Impurity A |
Dechloro Haloperidol Decanoate |
1797824-64-6 |
詳細(xì)
|
| Brivaracetam Impurity 60 |
布瓦西坦雜質(zhì)60 |
54374-02-6 |
詳細(xì)
|
| Baricitinib Impurity 31 |
1153949-15-5 |
1153949-15-5 |
詳細(xì)
|
| Propofol EP Impurity B |
2-異丙烯基-6-異丙基苯酚 |
74926-89-9 |
詳細(xì)
|
| Upadacitinib Impurity 16 |
烏帕替尼雜質(zhì)16 |
2715120-95-7 |
詳細(xì)
|
| Baloxavir Marboxil Impurity 6 |
Dibenzo[b,e]thiepin-11(6H)-one, 7-fluoro- |
2365473-57-8 |
詳細(xì)
|
| Baloxavir Marboxil Impurity 7 |
Dibenzo[b,e]thiepin-11-ol, 7-fluoro-6,11-dihydro- |
1820001-72-6 |
詳細(xì)
|
| Upadacitinib Impurity 98 |
烏帕替尼雜質(zhì)98 |
|
詳細(xì)
|
| Rizatriptan EP Impurity H |
利扎曲普坦N氧化物 |
260435-42-5 |
詳細(xì)
|
| Landiolol Impurity 57 |
蘭地洛爾雜質(zhì)57 |
940866-61-5 |
詳細(xì)
|
| Bumetanide Impurity 13 |
4-氯-3-硝基-5-磺基苯甲酸 |
130262-91-8 |
詳細(xì)
|
| Nebivolol Impurity 37 |
奈必洛爾雜質(zhì)37 |
1335103-88-2 |
詳細(xì)
|
| Iguratimod Impurity 21 |
艾拉莫德雜質(zhì) |
544482-14-6 |
詳細(xì)
|
| Levofloxacin Impurity 24（Trifluoroacetate） |
左氧氟沙星雜質(zhì)24(雙三氟乙酸鹽) |
|
詳細(xì)
|
| Tedizolid Impurity 54 |
特地唑胺雜質(zhì)54 |
2295578-89-9 |
詳細(xì)
|
| Landiolol Impurity 53 |
福莫特羅雜質(zhì) |
108971-53-5 |
詳細(xì)
|
| Landiolol impurity 22 |
Landiolol |
944919-03-3 |
詳細(xì)
|
| Mosapride Impurity 24 |
4-苯基-3H-1,2,4-三唑啉-3,5-二酮 |
4233-33-4 |
詳細(xì)
|
| Mivacurium Chloride Impurity 47 |
N-(3,4-二甲氧基苯乙基)-2-(3,4,5-三甲氧基苯基)乙酰胺 |
7668-87-3 |
詳細(xì)
|
| Baloxavir Impurity 43 |
巴洛沙韋雜質(zhì)84 |
1820001-80-6 |
詳細(xì)
|
| Haloperidol Decanoate EP Impurity I |
氟哌啶醇癸酸EP雜質(zhì)I |
2512216-30-5 |
詳細(xì)
|
| Brexpiprazole Impurity 45 |
依匹哌唑雜質(zhì) |
2060027-95-2 |
詳細(xì)
|
| Rosuvastatin EP Impurity C(Calcium Salt) |
瑞舒伐他汀鈣EP雜質(zhì)C |
1422514-05-3 |
詳細(xì)
|
| Allisartan Isoproxil Impurity 15 |
阿利沙坦酯中間體 |
947331-22-8 |
詳細(xì)
|
| Rebamipide Impurity 4 |
2-氨基-3-(2-氧代-1,2-二氫喹啉-4-基)丙酸鹽酸鹽 |
4876-14-6 |
詳細(xì)
|
| Regadenoson Impurity 27 |
瑞加德松雜質(zhì) 27 |
|
詳細(xì)
|
| Iguratimod Impurity I(Hydrochloride) |
艾拉莫德雜質(zhì)I(鹽酸鹽) |
|
詳細(xì)
|
| Baloxavir Marboxil Impurity 5 |
巴洛沙韋酯雜質(zhì)5 |
|
詳細(xì)
|
| Avatrombopag Impurity 7 |
4-(4-氯噻吩-2-基)-5-(4-環(huán)己基哌嗪-1-基)噻唑-2-胺 |
570407-42-0 |
詳細(xì)
|
| Regadenoson Impurity 8 |
瑞加德松雜質(zhì)8 |
|
詳細(xì)
|
| Iguratimod Impurity 35 |
艾拉莫德雜質(zhì)35 |
|
詳細(xì)
|
| 2-Hydroxymethyl Loratadine |
2-羥甲基氯雷他定 |
609806-39-5 |
詳細(xì)
|
| Regadenoson Impurity 19 |
2-肼基腺苷 |
15763-11-8 |
詳細(xì)
|
| Dexamethasone Related Compound E |
地塞米松USP相關(guān)物質(zhì)E |
2991360-83-7 |
詳細(xì)
|
| Morinidazole Impurity 6 |
莫立硝唑雜質(zhì)5 |
1782143-94-5 |
詳細(xì)
|
| Axitinib Impurity 12 |
阿昔替尼雜質(zhì)K |
1959572-97-4 |
詳細(xì)
|
| Haloperidol Decanoate EP Impurity K |
Haloperidol Lauroate |
65135-24-2 |
詳細(xì)
|
| Baloxavir Impurity 70 |
巴洛沙韋雜質(zhì)70 |
2305694-60-2 |
詳細(xì)
|